About this Journal Submit a Manuscript Table of Contents
Advances in Urology
Volume 2012 (2012), Article ID 960835, 4 pages
http://dx.doi.org/10.1155/2012/960835
Clinical Study

High-Intensity Focused Ultrasound for Prostate Cancer: Long-Term Followup and Complications Rate

Department of Urology (Chief: P. Cortellini), University Hospital of Parma, Parma, Italy

Received 16 February 2012; Accepted 2 May 2012

Academic Editor: Eric Barret

Copyright © 2012 Umberto Maestroni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. D. Steinberg, B. S. Carter, T. H. Beaty, B. Childs, and P. C. Walsh, “Family history and the risk of prostate cancer,” Prostate, vol. 17, no. 4, pp. 337–347, 1990. View at Scopus
  2. R. Yancik, “Population aging and cancer: a cross-national concern,” Cancer Journal, vol. 11, no. 6, pp. 437–441, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Jo, H. Junichi, F. Tomohiro, I. Yoshinari, and F. Masato, “Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life,” BJU International, vol. 96, no. 1, pp. 43–47, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. W. J. Catalona and D. S. Smith, “Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results,” Journal of Urology, vol. 160, no. 6, pp. 2428–2434, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Maestroni, M. Ziveri, N. Azzolini et al., “High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results,” Acta Biomedica de l'Ateneo Parmense, vol. 79, no. 3, pp. 211–216, 2008. View at Scopus
  6. A. V. D'Amico, K. Cote, M. Loffredo, A. A. Renshaw, and D. Schultz, “Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer,” Journal of Clinical Oncology, vol. 20, no. 23, pp. 4567–4573, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Roach, G. Hanks, H. Thames Jr., et al., “Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of ROTG-ASTRO Phoenix Consensus Conference,” International Journal of Radiation Oncology, vol. 65, pp. 965–974, 2006.
  8. S. Madersbacher, M. Pedevilla, L. Vingers, M. Susani, and M. Marberger, “Effect of high-intensity focused ultrasound on human prostate cancer in vivo,” Cancer Research, vol. 55, no. 15, pp. 3346–3351, 1995. View at Scopus
  9. A. Gelet, J. Y. Chapelon, R. Bouvier et al., “Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience,” European Urology, vol. 29, no. 2, pp. 174–183, 1996. View at Scopus
  10. S. Crouzet, X. Rebillard, D. Chevallier et al., “Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients,” European Urology, vol. 58, no. 4, pp. 559–566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Holmberg, A. Bill-Axelson, F. Helgesen et al., “A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer,” The New England Journal of Medicine, vol. 347, no. 11, pp. 781–789, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Ragde, A. A. Elgamal, P. B. Snow, et al., “Ten-year disease free survival after transperineal sonography-guided iodine-125 brachytherapy with or without 45-gray external beam irradiation in the treatment of patients with clinically localized, low to high Gleason grade prostate carcinoma,” Cancer, vol. 83, pp. 989–1001, 1998.
  13. A. Blana, S. C. W. Brown, C. Chaussy et al., “High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure,” BJU International, vol. 104, no. 8, pp. 1058–1062, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Blana, F. J. Murat, B. Walter et al., “First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer,” European Urology, vol. 53, no. 6, pp. 1194–1203, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Chaussy and S. Thüroff, “The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection,” Current Urology Reports, vol. 4, no. 3, pp. 248–252, 2003. View at Scopus
  16. L. Poissonnier, J. Y. Chapelon, O. Rouvière et al., “Control of prostate cancer by transrectal HIFU in 227 patients,” European Urology, vol. 51, no. 2, pp. 381–387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Chaussy and S. Thüroff, “High-intensity focused ultrasound in the management of prostate cancer,” Expert Review of Medical Devices, vol. 7, no. 2, pp. 209–217, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Thüroff, C. Chaussy, G. Vallancien et al., “High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European Multicentric study,” Journal of Endourology, vol. 17, no. 8, pp. 673–677, 2003. View at Scopus